Global biotechnology industry market to hit USD 546.0 billion
The global biotechnology industry market size is projected to expand from USD 483.0 billion in 2024 to USD 546.0 billion by 2025, reflecting a robust compound annual growth rate (CAGR) of approximately 13.0%. Despite the economic uncertainties and post-Covid slump in recent times, biotech companies have demonstrated adaptability throughout 2024. The global biotech industry market size is estimated to grow from USD 483.0 billion in 2024 to USD 546.0 billion by 2025, at a growth rate of ~13.0%. Ongoing innovation, mergers, and acquisitions (M&A), investments, and increasing focus on advanced therapies contribute to the sustained growth of the market. The global biotechnology industry is set to experience rapid growth and innovation, driven by advances in personalized medicine, AI integration, and the increasing demand for biologics. The industry will see expanded use of biologic drugs, such as monoclonal antibodies and gene therapies, especially for complex diseases like cancer, genetic disorders, and autoimmune conditions. Personalized medicine will take center stage, with treatments tailored to individual genetic profiles, improving efficacy and reducing side effects. Additionally, the use of AI and machine learning will significantly accelerate drug discovery, clinical trial designs, and biomanufacturing processes, helping companies bring therapies to market faster and more cost-effectively. The biotechnology sector will also focus on sustainability, with a shift toward greener biomanufacturing practices. Innovations like single-use bioprocessing, continuous biomanufacturing, and eco-friendly production methods will reduce costs, improve product yield, and minimize the environmental footprint of biologics production.
The Global Biotech Industry Outlook for 2025 aims to provide insights into the anticipated performance of the biotech sectors, covering AI integration in drug discovery and the development of innovative therapies. The report will assess the industry’s performance in 2024 relative to 2023 and highlight the significant breakthroughs and notable transformations in the biotech landscape during 2024, with expectations of continued momentum into 2025. MarketsandMarkets
